Nucleic Acid Drugs for Prevention of Cardiac Rejection
Figure 1
Representative findings of allograft coronary arteries are shown. (a) demonstrates the effects of E2F decoy compared to controls (b) on the intimal hyperplasia which defines cardiac allograft vasculopathy. (Modified from reference [23].)
